Mode
Text Size
Log in / Sign up
N/A N=100 Basic Science

Estradiol Effects on Alcohol Across the Menstrual Cycle

Alcohol Use, Unspecified

Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Attentional Bias (Early Follicular Phase) — 347.99; 355.02 milliseconds

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Placebo (Drug); Alcohol (Drug)
Age
Adult · 21+ yrs
Sex
Female
Sponsor
Mark Fillmore
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Attentional Bias (Early Follicular Phase)
347.99; 355.02
PRIMARY
Attentional Bias (Late Follicular Phase)
356.01; 352.81
PRIMARY
Disinhibition (Early Follicular Phase)
0.107; 0.04
PRIMARY
Disinhibition (Late Follicular Phase)
0.134; 0.045
PRIMARY
Subjective Ratings of the Rewarding Effects of Alcohol (Early Follicular Phase)
56.99; 39.2
PRIMARY
Subjective Ratings of the Rewarding Effects of Alcohol (Late Follicular Phase)
60.17; 39.43

Summary

This study will provide the first rigorous integrative test of the hypothesis that rapid rises in estradiol (a female hormone) increase the rewarding and disinhibiting effects of alcohol and that such increased sensitivity correlates with increased alcohol use. Identification of the behavioral mechanisms by which estradiol surges can increase alcohol use would provide a critical advancement of neurobiological theory of alcohol abuse in women, an understudied area, as well as provide new directions for personalization of alcohol abuse treatment in women. In this study, naturally-cycling women will be examined daily over their menstrual cycle using an integrative combination of daily ecological assessments of hormone fluctuations and alcohol use along with strategically-timed laboratory tests of their acute sensitivity to the rewarding and disinhibiting effects of a controlled dose of alcohol.

Eligibility Criteria

Inclusion Criteria

  • female
  • regular menstrual cycle
  • consume alcohol at least once per week
  • no history of drug or alcohol dependence

Exclusion Criteria

  • use of hormone-based medications
  • irregular menstrual cycle
  • current pregnancy
  • primary sensorimotor handicap
  • frank neurological disorder
  • pervasive developmental disorder
  • frank psychosis
  • diagnosed intellectual disability
  • medical condition contraindicating alcohol use
  • substance abuse history (except nicotine)
  • body mass index (BMI) 30 or above
  • alcohol abstainer
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04595682). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search